Castle Biosciences, Inc. (CSTL)

Castle Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	587	581	620	1,085	1,337	587
Market Cap Growth	0.70%	-6.38%	-42.81%	-18.88%	127.84%	-
Enterprise Value	373	353	375	763	927	513
PE Ratio	-	-10.11	-9.24	-34.66	-130.01	196.20
PS Ratio	2.34	2.64	4.53	11.53	21.34	11.32
PB Ratio	1.46	1.48	1.55	2.63	3.22	6.90
P/FCF Ratio	-94.35	-30.19	-13.17	-48.30	261.29	96.55
P/OCF Ratio	45.22	-103.22	-14.89	-57.14	135.53	83.65
EV/Sales Ratio	1.49	1.61	2.74	8.11	14.80	9.89
EV/EBITDA Ratio	-22.05	-7.84	-6.43	-20.85	-130.70	49.92
EV/EBIT Ratio	-12.85	-6.15	-5.44	-19.07	-122.55	51.73
EV/FCF Ratio	-61.12	-18.35	-7.96	-33.98	181.20	84.42
Debt / Equity Ratio	0.06	0.04	0.03	0.02	-	0.30
Debt / EBITDA Ratio	-1.40	-0.34	-0.23	-0.22	-	2.44
Debt / FCF Ratio	-3.89	-0.80	-0.28	-0.36	-	4.13
Quick Ratio	8.85	5.93	7.84	13.99	20.30	7.48
Current Ratio	9.26	6.20	8.09	14.22	20.58	7.63
Asset Turnover	0.57	0.51	0.30	0.21	0.26	0.73
Interest Coverage	-1459.19	-5214.00	-4052.18	-40011.00	-2.87	2.17
Return on Equity (ROE)	-7.90%	-14.90%	-16.50%	-7.50%	-5.00%	21.00%
Return on Assets (ROA)	-6.90%	-13.20%	-14.90%	-7.10%	-4.20%	4.20%
Return on Capital (ROIC)	-9.81%	-16.72%	-22.10%	-9.55%	-1.57%	6.56%
Earnings Yield	-5.25%	-9.90%	-10.82%	-2.89%	-0.77%	0.51%
FCF Yield	-1.10%	-3.31%	-7.59%	-2.07%	0.38%	1.04%
Buyback Yield / Dilution	-3.30%	-2.87%	-3.65%	-32.80%	-118.63%	-354.25%
Total Shareholder Return	-3.30%	-2.87%	-3.65%	-32.80%	-118.63%	-354.25%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).